Chondroitin sulfate;
Nile blue sulfate;
Resonance Rayleigh scattering;
Dual-wavelength overlapping;
Second order scattering;
Frequence doubling scattering;
CRYSTAL VIOLET;
SURFACTANT;
SODIUM;
D O I:
10.1016/j.saa.2011.08.059
中图分类号:
O433 [光谱学];
学科分类号:
0703 ;
070302 ;
摘要:
A dual-wavelength overlapping resonance Rayleigh scattering (DWO-RRS) method was developed to detect chondroitin sulfate (CS) with nile blue sulfate (NBS). At pH 3.0-4.0 Britton-Robinson (BR) buffer medium, CS interacted with NBS to form an ion-association complex. As a result, the new spectra of resonance Rayleigh scattering (RRS), second order scattering (SOS) and frequence doubling scattering (FDS) appeared and their intensities were enhanced greatly. Their maximum wavelengths were located at 303 nm (RRS), 362 nm (RRS), 588 nm (SOS) and 350 nm (FDS), respectively. The scattering intensities of the three methods were proportional to the concentration of CS in certain ranges. The methods had high sensitivity and the detection limits were between 1.5 and 7.1 ng mL(-1). The DWO-RRS method had the highest sensitivity with the detection limit being 1.5 ng mL(-1). The characteristics of the spectra and optimal reaction conditions of RRS method were investigated. The effects of coexistent substances on the determination of CS were evaluated. Owing to the high sensitivity. RRS method had been applied to the determination of CS in eye drops with satisfactory results. The recovery range was between 99.4% and 104.6% and the relative standard deviation (RSD) was between 0.4% and 0.8%. In addition, the reasons for RRS enhancement were discussed and the shape of ion-association complex was characterized by atomic force microscopy (AFM). (C) 2011 Elsevier B.V. All rights reserved.
机构:
Kyoto Pharmaceut Ind Co Ltd, Novel Pharmaceut Labs, Analyt Dev Div, Nakagyo Ku, Kyoto 6048444, JapanKyoto Pharmaceut Ind Co Ltd, Novel Pharmaceut Labs, Analyt Dev Div, Nakagyo Ku, Kyoto 6048444, Japan
Funaoka, Tomoko
Tanizawa, Toshihiro
论文数: 0引用数: 0
h-index: 0
机构:
Kyoto Pharmaceut Ind Co Ltd, Novel Pharmaceut Labs, Analyt Dev Div, Nakagyo Ku, Kyoto 6048444, JapanKyoto Pharmaceut Ind Co Ltd, Novel Pharmaceut Labs, Analyt Dev Div, Nakagyo Ku, Kyoto 6048444, Japan
Tanizawa, Toshihiro
Muro, Hiroyuki
论文数: 0引用数: 0
h-index: 0
机构:
Kyoto Pharmaceut Ind Co Ltd, Novel Pharmaceut Labs, Analyt Dev Div, Nakagyo Ku, Kyoto 6048444, JapanKyoto Pharmaceut Ind Co Ltd, Novel Pharmaceut Labs, Analyt Dev Div, Nakagyo Ku, Kyoto 6048444, Japan
Muro, Hiroyuki
Makino, Tadashi
论文数: 0引用数: 0
h-index: 0
机构:
Kyoto Pharmaceut Ind Co Ltd, Novel Pharmaceut Labs, Analyt Dev Div, Nakagyo Ku, Kyoto 6048444, JapanKyoto Pharmaceut Ind Co Ltd, Novel Pharmaceut Labs, Analyt Dev Div, Nakagyo Ku, Kyoto 6048444, Japan
机构:
SW China Normal Univ, Sch Chem & Chem Engn, Chongqing 400715, Peoples R ChinaSW China Normal Univ, Sch Chem & Chem Engn, Chongqing 400715, Peoples R China
Wei, XQ
Liu, ZF
论文数: 0引用数: 0
h-index: 0
机构:
SW China Normal Univ, Sch Chem & Chem Engn, Chongqing 400715, Peoples R ChinaSW China Normal Univ, Sch Chem & Chem Engn, Chongqing 400715, Peoples R China
Liu, ZF
Liu, SP
论文数: 0引用数: 0
h-index: 0
机构:
SW China Normal Univ, Sch Chem & Chem Engn, Chongqing 400715, Peoples R ChinaSW China Normal Univ, Sch Chem & Chem Engn, Chongqing 400715, Peoples R China